Correlation Between Tarsus Pharmaceuticals and Centessa Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Centessa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Centessa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Centessa Pharmaceuticals PLC, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Centessa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Centessa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Centessa Pharmaceuticals.
Diversification Opportunities for Tarsus Pharmaceuticals and Centessa Pharmaceuticals
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Tarsus and Centessa is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Centessa Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centessa Pharmaceuticals and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Centessa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centessa Pharmaceuticals has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Centessa Pharmaceuticals go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Centessa Pharmaceuticals
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.93 times more return on investment than Centessa Pharmaceuticals. However, Tarsus Pharmaceuticals is 1.07 times less risky than Centessa Pharmaceuticals. It trades about 0.28 of its potential returns per unit of risk. Centessa Pharmaceuticals PLC is currently generating about 0.14 per unit of risk. If you would invest 3,967 in Tarsus Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 865.00 from holding Tarsus Pharmaceuticals or generate 21.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Centessa Pharmaceuticals PLC
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Centessa Pharmaceuticals |
Tarsus Pharmaceuticals and Centessa Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Centessa Pharmaceuticals
The main advantage of trading using opposite Tarsus Pharmaceuticals and Centessa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Centessa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centessa Pharmaceuticals will offset losses from the drop in Centessa Pharmaceuticals' long position.| Tarsus Pharmaceuticals vs. Capricor Therapeutics | Tarsus Pharmaceuticals vs. Soleno Therapeutics | Tarsus Pharmaceuticals vs. Bio Path Holdings | Tarsus Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |